1-3 of 3
Kyle Chan, PhD.
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Targeting the p27 Kip1 E3 Ubiquitin Ligase for the Treatment of Multiple Myeloma and Other Hematological Malignancies.

Qing Chen, PhD, Weilin Xie, PhD, Deborah J. Kuhn, PhD, Peter M. Voorhees, MD, Derek Mendy, MD, Antonia Lopez-Girona, PhD, Veronique Plantevin, PhD, Weiming Xu, PhD, Laura De Parseval, PhD, Laura G. Corral, PhD, Emilia Glezer, PhD, Kyle Chan, PhD, Frank Mercurio, PhD, Robert Z. Orlowski, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 372.
https://doi.org/10.1182/blood.V108.11.372.372
Published: 2006
Journal Articles

Lenalidomide and Novel Immunomodulatory Drugs (IMiDs®): A New Approach to the Regulation of Erythropoiesis and Hemoglobin Synthesis in Anemia.

Laure Moutouh de Parseval, MD, Helen Brady, Ph.D, Dominique Verhelle, PhD, Laura G. Corral, MS, Emilia Glezer, BS, Christopher L. Morris, MD, PhD, Roger Chen, PhD, Kyle Chan, PhD
Journal: Blood
Blood (2005) 106 (11): 2702.
https://doi.org/10.1182/blood.V106.11.2702.2702
Published: 2005
Journal Articles

Novel Immunomodulatory Drugs (IMiDs®): A Potential, New Therapy for β-Hemoglobinopathies.

Laure Moutouh de Parseval, MD., Helen Brady, PhD., Emila Glezer, MS., Normand Richard, MS., George Muller, PhD., Christopher L. Morris, MD., PhD., Dave Stirling, PhD., Kyle Chan, PhD.
Journal: Blood
Blood (2004) 104 (11): 3740.
https://doi.org/10.1182/blood.V104.11.3740.3740
Published: 2004